This topic contains a solution. Click here to go to the answer

Author Question: The ____ dimension in Maslach's three dimensional model of burnout refers to disillusionment, a loss ... (Read 25 times)

Chelseaamend

  • Hero Member
  • *****
  • Posts: 545
The ____ dimension in Maslach's three dimensional model of burnout refers to disillusionment, a loss of idealism, negativity, detachment, hostility, and lack of concern.
 
  a. reduced efficacy c. cynicism
  b. emotional exhaustion d. dehumanizing

Question 2

In the ____ dimension of Maslach's three dimensional model of burnout, a person feels emotionally depleted, drained, and lacking in emotional resources.
 
  a. emotional exhaustion c. depersonalization
  b. cynicism d. reduced efficacy



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

fatboyy09

  • Sr. Member
  • ****
  • Posts: 358
Answer to Question 1

C

Answer to Question 2

A




Chelseaamend

  • Member
  • Posts: 545
Reply 2 on: Jun 22, 2018
YES! Correct, THANKS for helping me on my review


tanna.moeller

  • Member
  • Posts: 328
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

Famous people who died from poisoning or drug overdose include, Adolf Hitler, Socrates, Juan Ponce de Leon, Marilyn Monroe, Judy Garland, and John Belushi.

Did you know?

Bacteria have flourished on the earth for over three billion years. They were the first life forms on the planet.

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library